Ensysce Biosciences, Inc. (ENSC) Executive Compensation
Ensysce Biosciences, Inc. (ENSC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ENSC
CIK: 1716947
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerCarisa Wisniewski
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-25 | 8-K | 0001493152-26-044802 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-25 | 8-K | 0001493152-26-040080 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-24 | 8-K | 0001493152-26-039898 | View SEC Doc Filr Page |
| D | 2026-08-20 | — | D Filing | 0001493152-26-039439 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-18 | — | SCHEDULE 13D/A Filing | 0001493152-26-038943 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-04-23 | 4 | 0001493152-26-038866 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037817 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037794 | View SEC Doc Filr Page |
| 3 | 2026-08-10 | 2026-08-05 | 3 | 0001493152-26-036856 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-06 | 2026-08-05 | 8-K/A | 0001493152-26-036326 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-05 | 8-K | 0001493152-26-036268 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | 8-K | 0001493152-26-033360 | View SEC Doc Filr Page |
| EFFECT | 2026-06-26 | — | EFFECT Filing | 9999999995-26-002133 | View SEC Doc Filr Page |
| S-3 | 2026-06-04 | — | S-3 | 0001493152-26-027289 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-22 | 8-K | 0001493152-26-025061 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023811 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-15 | 8-K | 0001493152-26-023810 | View SEC Doc Filr Page |
| S-8 | 2026-04-30 | — | S-8 | 0001493152-26-020504 | View SEC Doc Filr Page |
| EFFECT | 2026-04-15 | — | EFFECT Filing | 9999999995-26-001203 | View SEC Doc Filr Page |
| CORRESP | 2026-04-14 | — | CORRESP Filing | 0001493152-26-016449 | View SEC Doc Filr Page |
| UPLOAD | 2026-04-13 | — | UPLOAD Filing | 0000000000-26-003700 | View SEC Doc Filr Page |
| S-3 | 2026-04-09 | — | S-3 | 0001493152-26-015763 | View SEC Doc Filr Page |
| 8-K | 2026-04-08 | 2026-04-07 | 8-K | 0001493152-26-015602 | View SEC Doc Filr Page |
| 8-K | 2026-04-03 | 2026-04-03 | 8-K | 0001493152-26-015139 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001493152-26-013633 | View SEC Doc Filr Page |